Investment
Participated in Anaheim Bio's oversubscribed EUR 40M Series A to take ANA1 into the clinic.
Anaheim Bio
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Anaheim Bio
Magnolia MedTech Fund
Michel de Baar joined as Venture Partner